Mixed Tumor, Mullerian - 25 Studies Found
Completed |
: Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer :
: 2004-01-09 :
|
Not yet recruiting |
: microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer : Prostate Carcinosarcoma : 2016-11-08 : Biological: High PSA levels |
No longer available |
: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient : Mullerian Mixed Tumor of Ovary : 2014-03-14 : Drug: ficlatuzumab humanized anti-hepatocyte growth factor (HGF) monoclonal antibody IV administration a |
Completed |
: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors :
|
Recruiting |
: Suitability of DCE-MRI for Detection of Vascular Changes After VBT : Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus : 2013-11-11 : Radiation: Radiotherapy |
Recruiting |
: A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma : Recurrent Endometrial Cancer : 2011-09-28 : Drug: Lapatinib and ixempra Ixabepilone 40 mg/m2 Lapatinib 250 mg |
Completed |
: Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer :
|
Terminated |
: Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus : Sarcoma : 2000-11-06 : Drug: topotecan hydrochloride |
Recruiting |
: A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer :
|
Completed |
: Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors :
|